Advertisement
Advertisement
RPID
Rapid Micro Biosystems, Inc. Class A Common Stock
2.13
USDSponsored
+0.02
+0.95%
Jul 31, 15:59 UTC -4
Closed
After-Market
2.16
+0.03
+1.36%
RPID Earnings Reports
Positive Surprise Ratio
RPID beat 8 of 20 last estimates.
40%
Next Report
Next Week
Date of Next Report
Aug 07, 2026
Estimate for Q2 26 (Revenue/ EPS)
$8.03M
/-$0.24
Implied change from Q1 26 (Revenue/ EPS)
+0.38%
/-22.58%
Implied change from Q2 25 (Revenue/ EPS)
+10.61%
/-11.11%
Rapid Micro Biosystems, Inc. Class A Common Stock earnings per share and revenue
On May 13, 2026, RPID reported earnings of -0.31 USD per share (EPS) for Q1 26, missing the estimate of -0.25 USD, resulting in a -23.21% surprise. Revenue reached 8.00 million, compared to an expected 7.75 million, with a 3.22% difference. The market reacted with a -6.45% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 8.03 million USD, implying an decrease of -22.58% EPS, and increase of 0.38% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Axogen, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.12
Actual
$0.12
Surprise
-3.15%
iRadimed Corporation
Report Date
Jul 31, 2026 For Q2 26
Estimate
$0.42
Actual
$0.46
Surprise
+7.38%
Integra LifeSciences Holdings
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.49
Actual
$0.56
Surprise
+13.57%
Beta Bionics, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.53
Surprise
+12.77%
IQVIA Holdings Inc.
Report Date
Jul 28, 2026 For Q2 26
Estimate
$3.06
Actual
$3.15
Surprise
+2.92%
DexCom, Inc.
Report Date
Jul 30, 2026 For Q1 26
Estimate
$0.62
Actual
$0.70
Surprise
+12.38%
DexCom, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.68
Actual
$0.70
Surprise
+1.92%
Penumbra, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$1.08
Actual
$0.88
Surprise
-18.96%
Glaukos Corporation
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.21
Actual
-$0.14
Surprise
+34.85%
Veracyte, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.24
Actual
$0.31
Surprise
+28.15%
FAQ
What were Rapid Micro Biosystems, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Rapid Micro Biosystems, Inc. Class A Common Stock reported EPS of -$0.31, missing estimates by -23.21%, and revenue of $8.00M, 3.22% above expectations.
How did the market react to Rapid Micro Biosystems, Inc. Class A Common Stock's Q1 2026 earnings?
The stock price moved down -6.45%, changed from $2.48 before the earnings release to $2.32 the day after.
When is Rapid Micro Biosystems, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Aug 07, 2026.
What are the forecasts for Rapid Micro Biosystems, Inc. Class A Common Stock's next earnings report?
Based on 3
analysts, Rapid Micro Biosystems, Inc. Class A Common Stock is expected to report EPS of -$0.24 and revenue of $8.03M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement